Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD

被引：0
|
作者：
Heidi Fassnacht-Riederle
Matthias Becker
Nicole Graf
Stephan Michels
机构：
[1] City Hospital Triemli,Department of Ophthalmology
[2] University of Heidelberg,Department of Ophthalmology
[3] Graf Biostatistics,undefined
[4] University of Zurich,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2014年 / 252卷
关键词：
Age-related macular degeneration; Aflibercept; Ranibizumab; Bevacizumab; Tolerance; Tachyphylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1705 / 1709
页数：4
相关论文
共 50 条
  • [21] Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema
    Rahimy, Ehsan
    Shahlaee, Abtin
    Khan, M. Ali
    Ying, Gui-Shuang
    Maguire, Joseph
    Ho, Allen
    Regillo, Carl D.
    Hsu, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [22] Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
    Rahimy, Ehsan
    Shahlaee, Abtin
    Khan, M. Ali
    Ying, Gui-Shuang
    Maguire, Joseph I.
    Ho, Allen C.
    Regillo, Carl D.
    Hsu, Jason
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 164 : 118 - 127
  • [23] Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
    Boscia, Giacomo
    Pozharitskiy, Nikolai
    Grassi, Maria Oliva
    Borrelli, Enrico
    D'Addario, Marina
    Alessio, Giovanni
    Boscia, Francesco
    Viggiano, Pasquale
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [24] Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
    Giacomo Boscia
    Nikolai Pozharitskiy
    Maria Oliva Grassi
    Enrico Borrelli
    Marina D’Addario
    Giovanni Alessio
    Francesco Boscia
    Pasquale Viggiano
    Scientific Reports, 14
  • [25] The SWIM 2 (Switching from Intermittent Anti-VEGF to Monthly Therapy in Neovascular AMD) Study
    Kashiwa, Kellen
    Bennett, Michael
    Hooten, Claudia
    Demaine, Kent
    Milroy, Christopher
    Stark, Bryn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [26] The role of Stratus OCT in anti-VEGF therapy.: Qualitative and quantitative assessment of neovascular AMD
    Bolz, M.
    Ritter, M.
    Polak, K.
    Ahlers, C.
    Hirn, C.
    Pruente, C.
    Golbaz, I.
    Benesch, T.
    Schmidt-Erfurth, U.
    OPHTHALMOLOGE, 2008, 105 (07): : 650 - 655
  • [27] Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
    Mettu, Priyatham S.
    Allingham, Michael J.
    Cousins, Scott W.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2021, 82
  • [28] Effect of Anti-VEGF Therapy on Intraocular Biochemical Profile in Neovascular Conditions
    Sharma, R. K.
    Rogojina, A. T.
    Chalam, K. V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [29] The Effect of Cigarette Smoking on Anti-VEGF Therapy Response in Exudative AMD
    Shen, Leo Liyuan
    Anant, Shruti
    Wang, Dorothy
    Pan, Annabelle
    Ahmed, Aishah
    Schuweiler, Mark
    Handa, James T.
    Shen, Leo Liyuan
    Anant, Shruti
    Wang, Dorothy
    Pan, Annabelle
    Ahmed, Aishah
    Schuweiler, Mark
    Handa, James T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [30] Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization
    Zhang, Zhao
    Shen, Megan M.
    Fu, Yingbin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (12)
12345